In vivo targeting of de novo DNA methylation by histone modifications in yeast and mouse

  1. Marco Morselli  Is a corresponding author
  2. William A Pastor
  3. Barbara Montanini
  4. Kevin Nee
  5. Roberto Ferrari
  6. Kai Fu
  7. Giancarlo Bonora
  8. Liudmilla Rubbi
  9. Amander T Clark
  10. Simone Ottonello
  11. Steven E Jacobsen  Is a corresponding author
  12. Matteo Pellegrini  Is a corresponding author
  1. University of California, Los Angeles, United States
  2. Laboratory of Functional Genomics and Protein Engineering, Italy
  3. Howard Hughes Medical Institute, University of California, Los Angeles, United States

Decision letter

  1. Bing Ren
    Reviewing Editor; University of California, San Diego School of Medicine, United States

eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see review process). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled “In vivo targeting of de novo DNA methylation by histone modifications in yeast and mouse” for consideration at eLife. Your article has been favorably evaluated by a Senior editor and three reviewers, one of whom, Bing Ren, is a member of our Board of Reviewing Editors.

The Reviewing editor and the other reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

All reviewers agreed that your findings are important in understanding what determines the specificity of the DNA methylation machinery and that your experimental approach of expressing DNMT3b in an organism that lacks DNA methylation is unique and creative. Unfortunately, many key findings have just been published on January 21 in the journal Nature (Baubec et al. 2015). However, since your manuscript was submitted before the publication of Baubec et al., the editors decided to proceed with the review process. In this case, we would like to ask you to revise your manuscript swiftly by addressing the comments below and return your revision within four weeks (the sooner the better), in order for us to further consider publication.

1) The authors have to provide a clear rationale for their selection of DNMT3b only (instead of DNMT3a or both) to study de novo DNA methylation, since DNMT3a has been shown to have stronger enzymatic activity than DNMT3b in (Baubec et al. 2015), and DNMT3a (but not DNMT3b) is frequently mutated in tumors.

2) The authors need to discuss any differences of their work in comparison with Baubec et al. 2015.

3) The final section on mouse male germline DNA methylation is the least developed, but this should not prove difficult to improve. Many results and conclusions in the section “Correspondence between H3K36me3 and early DNA methylation in mammalian cells” are primarily supported by browser captures (Figure 6B–D) rather than quantitative plots. This is not appropriate. Furthermore, there is a paucity of summary information on the WGBS experiments. An intelligent reader will refer to this in supplementary data in order to judge the reliability of the data.

https://doi.org/10.7554/eLife.06205.028

Author response

In this case, we would like to ask you to revise your manuscript swiftly by addressing the comments below and return your revision within four weeks of time (the sooner the better), in order for us to further consider publication.

1) The authors have to provide a clear rationale for their selection of DNMT3b only (instead of DNMT3a or both) to study de novo DNA methylation, since DNMT3a has been shown to have stronger enzymatic activity than DNMT3b in (Baubec et al. 2015), and DNMT3a (but not DNMT3b) is frequently mutated in tumors.

We expressed both murine de novo DNA methyltransferases in yeast, but we weren’t able to detect any expression both at RNA and protein levels of the murine DNMT3a in our transformed yeast strains. Moreover, whole genome bisulfite sequencing data of the DNMT3a strains do not show any level of DNA methylation. We do not understand the reason for why DNMT3a expression did not work, while DNMT3b did.

2) The authors need to discuss any differences of their work in comparison with Baubec et al. 2015.

Discussion of similarities and differences have been included in the Introduction and Discussion sections of the manuscript, as illustrated below.

Introduction, fifth paragraph: “Recently it has been reported that the PWWP domain is important in specifying the localization of DNMT3b in mouse embryonic stem cells (Baubec et al., 2015).”

Discussion, first paragraph: “It has been recently shown (Baubec et al., 2015) that in embryonic stem cells the PWWP domain is responsible for the targeting of DNMT3b […] and during a period of biologically important de novo DNA methylation (germ cells).”

Discussion, second paragraph: “In our yeast system we detected an anti-correlation between transcript levels and DNA methylation […] into the gene-body, shaping their intragenic DNA methylation distribution.”

3) The final section on mouse male germline DNA methylation is the least developed, but this should not prove difficult to improve. Many results and conclusions in the sectionCorrespondence between H3K36me3 and early DNA methylation in mammalian cellsare primarily supported by browser captures (Figure 6B–D) rather than quantitative plots. This is not appropriate. Furthermore, there is a paucity of summary information on the WGBS experiments. An intelligent reader will refer to this in supplementary data in order to judge the reliability of the data.

Figure 6C was modified: the previous genome browser snapshot (which was similar to that of 6D) was substituted with a quantitative plot showing that regions with high H3K36me3 levels at E13.5 are associated with the de novo DNA methylation increase occurring between E13.5 and E16.5. Data from WGBS experiments in mice (Pastor et al., 2014 and Seisenberger et al., 2012) were summarized in Supplementary file 1 panel G and Supplementary file 2 panel C, in the same manner as the yeast DNA methylation data. Also, Figures 6E and 6F are quantitative metaplots over all protein coding genes, which show global correlation of DNA methylation and H3K36me3 (6F) and anti-correlation with H3K4me3 (6E).

https://doi.org/10.7554/eLife.06205.029

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Marco Morselli
  2. William A Pastor
  3. Barbara Montanini
  4. Kevin Nee
  5. Roberto Ferrari
  6. Kai Fu
  7. Giancarlo Bonora
  8. Liudmilla Rubbi
  9. Amander T Clark
  10. Simone Ottonello
  11. Steven E Jacobsen
  12. Matteo Pellegrini
(2015)
In vivo targeting of de novo DNA methylation by histone modifications in yeast and mouse
eLife 4:e06205.
https://doi.org/10.7554/eLife.06205

Share this article

https://doi.org/10.7554/eLife.06205